Articles with public access mandates - Luca ValentiLearn more
Not available anywhere: 14
Review
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ...
Journal of hepatology 75 (4), 786-794, 2021
Mandates: National Institute for Health Research, UK, European Commission, Government …
Review
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD
E Corradini, E Buzzetti, P Dongiovanni, S Scarlini, A Caleffi, S Pelusi, ...
Journal of Hepatology 75 (3), 506-513, 2021
Mandates: European Commission, Government of Italy, AIRC Foundation for Cancer …
Review
The UCP2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
R Fares, S Petta, R Lombardi, S Grimaudo, P Dongiovanni, R Pipitone, ...
Liver International 35 (5), 1574-1580, 2015
Mandates: Government of Italy
Review
Genetics of nonalcoholic fatty liver disease: a 2018 update
LVC Valenti, GA Baselli
Current pharmaceutical design 24 (38), 4566-4573, 2018
Mandates: Government of Italy
Review
Genetic risk scores and personalization of care in fatty liver disease
C Bianco, F Tavaglione, S Romeo, L Valenti
Current Opinion in Pharmacology 61, 6-11, 2021
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council, European …
Review
Genetics and epigenetics in the clinic: precision medicine in the management of fatty liver disease
A Cespiati, NA Youngson, A Tourna, L Valenti
Current Pharmaceutical Design 26 (10), 998-1009, 2020
Mandates: European Commission, Government of Italy, AIRC Foundation for Cancer …
Review
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD
P Dongiovanni, M Meroni, S Petta, M Longo, A Alisi, G Soardo, L Valenti, ...
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2020
Mandates: Government of Italy
Review
SIRT5 rs12216101 T> G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
F Salomone, RM Pipitone, M Longo, F Malvestiti, AM Amorini, A Distefano, ...
Journal of Hepatology 80 (1), 10-19, 2024
Mandates: European Commission
Review
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
A Cherubini, S Della Torre, S Pelusi, L Valenti
Trends in Molecular Medicine, 2024
Mandates: European Commission
Review
PNPLA3 I148M genetic variant and kidney disease
S Romeo, P Dongiovanni, S Petta, J Pihalajamaki, L Valenti
Hepatology, 2014
Mandates: National Fund for Scientific Research, Belgium
Review
Genetics of MASLD: The State of Art Update.
S Sookoian, Y Rotman, L Valenti
Clinical Gastroenterology and Hepatology, 2024
Mandates: European Commission
Review
Poor accuracy and sustainability of the first‐step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population
A De Vincentis, F Tavaglione, S Namba, M Kanai, Y Okada, Y Kamatani, ...
Alimentary Pharmacology & Therapeutics 59 (11), 1402-1412, 2024
Mandates: Knut and Alice Wallenberg Foundation, European Commission
Review
Combined hepatic and adipose tissue transcriptomics highlights circulating NASH biomarkers
M Meroni, E De Caro, F Chiappori, M Longo, E Paolini, E Mosca, I Merelli, ...
Digestive and Liver Disease 55, S32-S33, 2023
Mandates: European Commission, Government of Italy
Review
Risk of liver disease in first-degree relatives of patients with advanced NAFLD: initial data from an Italian cohort study
A Cespiati, S Pelusi, S Maier, R Lombardi, G Baselli, P Dongiovanni, ...
Digestive and Liver Disease 51, e23, 2019
Mandates: Government of Italy
Available somewhere: 197
Review
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ...
Journal of hepatology 73 (1), 202-209, 2020
Mandates: National Health and Medical Research Council, Australia, National Institute …
Review
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
Mandates: National Health and Medical Research Council, Australia, National Institute …
Review
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
Mandates: German Research Foundation, Government of Spain, Government of Italy
Review
Genetics and epigenetics of NAFLD and NASH: Clinical impact
M Eslam, L Valenti, S Romeo
Journal of hepatology 68 (2), 268-279, 2018
Mandates: National Health and Medical Research Council, Australia, Swedish Research …
Review
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
Mandates: US National Institutes of Health, Health Research Board, Ireland, UK Medical …
Review
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
Mandates: US National Institutes of Health, Swedish Research Council
Publication and funding information is determined automatically by a computer program